Beactica Therapeutics

📍 Uppsala, Sweden🗓 Founded 2006👥 17 employees💰 Last funded Jan 2015
Pharmaceutical Manufacturing🌐 beactica.com
Website LinkedIn
Beactica Therapeutics is a specialist drug discovery and development company, committed to the fight against cancer. Beactica is advancing a proprietary pipeline of first-in-class therapeutics by applying its molecular interaction-based drug discovery engine synergistically across multiple small molecule modalities – including allosteric modulators, protein–protein interaction inhibitors and targeted protein degraders (PROTACs).
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2006
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Angel investors· 1
Jens Mogensen 🔸
Jens Mogensen 🔸
Strategy and Startups
Angel Investor
late stage
3 investments
Jan 2015
Early stage· 1
?
Board Member
early stage
Aug 2006
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Beactica Therapeutics?
Beactica Therapeutics has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Beactica Therapeutics last raise funding?
The most recent investment in Beactica Therapeutics recorded on gritt.io was in January 2015.
When was Beactica Therapeutics founded?
Beactica Therapeutics was founded in 2006.
What industry is Beactica Therapeutics in?
Beactica Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Beactica Therapeutics based?
Beactica Therapeutics is headquartered in Uppsala, Sweden.